Dr. Jie Gan, independent director and member of CBP's Audit Committee, has been appointed to serve as the Chair of CBP's Compensation Committee and as a member of the Governance and Nominating Committee. Dr. Gan brings a wealth of financial consulting experience to CBP. She serves as an associate professor with tenure in the Department of Finance at the Hong Kong University of Science and Technology. Her areas of research expertise include pharmaceutical company valuation in the areas of accounting statements, cash flow forecasts, and cost of capital estimations. Dr. Gan received her PhD in Financial Economics from the Massachusetts Institute of Technology and her Bachelor's degree from Nanjing University in China.
Dr. Tong Jun Lin, independent director and member of CBP's Audit Committee, has been appointed to serve as the Chair of CBP's Governance and Nominating Committee and as a member of the Compensation Committee. Dr. Lin has over 20 years of medical research experience. He is an associate professor with tenure in the Departments of Microbiology and Immunology and Pediatrics at the Dalhousie University. Dr. Lin has been involved in the studies of immunological mechanisms in the host defense against microbial pathogens and allergens. Dr. Lin received his MD (1984) from The First Military Medical University in Guangzhou, China and PhD (1990) degree from the Institute of Materia Medica Chinese Academy of Medical Sciences in Beijing, China. He received his post-doctoral training at the University of Alberta, Duke University and Dalhousie University.
About China Biologic Products, Inc.
Through its indirect majority-owned subsidiary Shandong Taibang
Biological Products Co. Ltd., China Biologic Products, Inc. (the
''Company''), is principally engaged in the research, development,
production and manufacturing and sale of pl
|SOURCE China Biologic Products, Inc.|
Copyright©2008 PR Newswire.
All rights reserved